United States· US:65162-468_4480ac35-28fd-48fc-b0eb-52349d30ad8e
Clindamycin Palmitate Hydrochloride
A clindamycin product containing clindamycin palmitate hydrochloride, registered in United States by Amneal Pharmaceuticals LLC. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Clindamycin is registered in 14 of 19 countries.
Countries holding a registration under ATC G01AA10 (clindamycin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Clindamycin · ATC G01AA10
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of clindamycin costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), so markets compare like for like.
- United States: $0.063 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Clindamycin · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- US United States$0.063 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Clindamycin Palmitate Hydrochloride
- Manufacturer
- Amneal Pharmaceuticals LLC
- Country
- United States (US)
- ATC code
- G01AA10
- ATC class
- Clindamycin
- Defined daily dose
- 0.1 g, V
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc1165162468191 BOTTLE in 1 CARTON (65162-468-19) / 100 mL in 1 BOTTLE
Regulatory notes
Interactions
10 interactions on record for clindamycin.
Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clindamycin · interactions on record
10 records
- 10 moderate
Most severe, free to view
- TubocurarineM03AA02moderate
- SuxamethoniumM03AB01moderate
- PancuroniumM03AC01moderate
- VecuroniumM03AC03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Clindamycin in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- United Kingdom (Northern Ireland) · Clindamycin Penlan Pharmaceuticals
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a872be6c-3f4e-4c9e-a804-3b0f66fc0a4b GET /v1/drugs/a872be6c-3f4e-4c9e-a804-3b0f66fc0a4b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "VN9A8JM7M7",
"rxcui": "91075",
"inchikey": "GTNDZRUWKHDICY-DJHAJVGHSA-N",
"display_name": "CLINDAMYCIN PALMITATE HYDROCHLORIDE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"27747e01-85eb-44de-a4a6-711a7799218a": {
"match": "brand_token",
"title": "CLINDAMYCIN PHOSPHATE SOLUTION [BRYANT RANCH PREPACK]",
"spl_version": "111",
"published_date": "2026-06-01"
}
},
"productid": "65162-468_4480ac35-28fd-48fc-b0eb-52349d30ad8e",
"productndc": "65162-468",
"dosage_form": "POWDER, FOR SOLUTION",
"orange_book": {
"appl_no": "203513",
"products": [
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "EQ 75MG BASE/5ML",
"product_no": "001",
"approval_date": "Mar 13, 2014"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "CLINDAMYCIN PALMITATE HYDROCHLORIDE",
"shortage_reason": "Clindamycin Palmitate Hydrochloride Injection",
"shortage_status": "current",
"proprietary_name": "Clindamycin Palmitate Hydrochloride",
"active_ingred_unit": "mg/5mL",
"application_number": "ANDA203513",
"marketing_category": "ANDA",
"nonproprietary_name": "Clindamycin Palmitate Hydrochloride",
"start_marketing_date": "20130902",
"active_numerator_strength": "75"
}See everything about clindamycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.